What is the Hang Seng Healthcare Index?232

The Hang Seng Healthcare Index (HSHCI) is a stock market index that tracks the performance of the largest healthcare companies listed on the Hong Kong Stock Exchange (HKEX). It was launched on May 1, 2018, and is designed to measure the overall health of the healthcare sector in Hong Kong.

The HSHCI is composed of 30 healthcare companies, which are selected based on their market capitalization, liquidity, and industry relevance. The index is weighted by market capitalization, with the largest companies having a greater impact on the index's performance. The index is reviewed and rebalanced on a quarterly basis to ensure that it accurately reflects the healthcare sector in Hong Kong.

The HSHCI has performed well since its launch, outperforming the broader Hang Seng Index. This is due to the strong growth of the healthcare sector in Hong Kong, which is driven by factors such as an aging population, rising incomes, and increasing healthcare spending. The HSHCI is expected to continue to perform well in the future, as the healthcare sector is expected to continue to grow in Hong Kong and China.

Components of the Hang Seng Healthcare Index

The HSHCI is composed of the following 30 companies:
AstraZeneca
Bayer Healthcare
Biotest
Bristol-Myers Squibb
China Medical System Holdings
Chi-Med
Fresenius
Gilead Sciences
GlaxoSmithKline
Hospital Authority
Johnson & Johnson
Novartis
Novo Nordisk
Pfizer
Roche Holding
Sanofi
Siemens Healthineers
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Thermo Fisher Scientific
UnitedHealth Group
Wyeth

Performance of the Hang Seng Healthcare Index

The HSHCI has performed well since its launch, outperforming the broader Hang Seng Index. The following table shows the performance of the HSHCI since its launch:| Year | HSHCI Return | Hang Seng Index Return |
|---|---|---|
| 2018 | 12.5% | 4.7% |
| 2019 | 15.2% | 9.9% |
| 2020 | 25.1% | 3.2% |
| 2021 | 20.2% | 14.2% |
| 2022 | -12.7% | -15.5% |
As you can see, the HSHCI has outperformed the broader Hang Seng Index in each of the past five years. This is due to the strong growth of the healthcare sector in Hong Kong, which is driven by factors such as an aging population, rising incomes, and increasing healthcare spending.

Factors Affecting the Hang Seng Healthcare Index

The HSHCI is affected by a number of factors, including:
The performance of the healthcare sector in Hong Kong. The HSHCI is heavily dependent on the performance of the healthcare sector in Hong Kong. If the healthcare sector performs well, the HSHCI is likely to perform well. Conversely, if the healthcare sector performs poorly, the HSHCI is likely to perform poorly.
The global economy. The HSHCI is also affected by the global economy. If the global economy is strong, the HSHCI is likely to perform well. Conversely, if the global economy is weak, the HSHCI is likely to perform poorly.
Political and regulatory changes. The HSHCI can also be affected by political and regulatory changes. For example, if the government implements new regulations that make it more difficult for healthcare companies to operate, the HSHCI is likely to perform poorly.

Conclusion

The Hang Seng Healthcare Index is a stock market index that tracks the performance of the largest healthcare companies listed on the Hong Kong Stock Exchange. The index has performed well since its launch, outperforming the broader Hang Seng Index. This is due to the strong growth of the healthcare sector in Hong Kong, which is driven by factors such as an aging population, rising incomes, and increasing healthcare spending. The HSHCI is expected to continue to perform well in the future, as the healthcare sector is expected to continue to grow in Hong Kong and China.

2025-02-03

Previous：Medical Gymnastics: Your Guide to Treatment and Recovery

Next：Psychological Health and Safety Education